You are here: Industry Insights > Market News

News List

Glucagon-like peptide-1 (GLP-1) Receptor Agonist Semaglutide in an Oleogel Formulation Using the BrainDos™ Technology Significantly Increases Drug Delivery into Cells PharmaSources
May 09, 2024
MetP Pharma AG, leveraging the proprietary nose-to-brain drug delivery technology BrainDos™ in internal and external product development and manufacturing programs.
On the Path to Net Zero: Vetter Achieves New Sustainability Goals in 2023 PharmaSources
May 09, 2024
Alongside its dynamic growth, Vetter announced that it achieved its sustainability goals for 2023.
The life science and biotech PR distribution service PharmaSources
May 06, 2024
Alfred Merz, PhD, has been appointed as Chief Operating Officer effective May 1st, 2024.
InnoCare Sets up Specific Environment Management Target in its Fifth ESG Report PharmaSources
April 28, 2024
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases.
Touchlight Awarded Grant Extension to Further Develop DNA-Enabled Biobatteries with U.S. Office for Naval Research and UK Defence Science & Technology Laboratory PharmaSources
April 26, 2024
Biobatteries use enzymes to generate electricity from the breakdown of complex fuels, such as carbohydrates, fatty acids and alcohols.
Study Results of Orelabrutinib in Patients with ITP Published by the American Journal of Hematology PharmaSources
April 18, 2024
The study provides compelling evidence for the potential of orelabrutinib as a safe and effective therapy for patients with ITP.
InnoCare Announces the Acceptance of New Drug Application for pan-TRK Inhibitor Zurletrectinib in China PharmaSources
April 16, 2025
InnoCare's zurletrectinib NDA for treating NTRK fusion - positive advanced solid tumors in adults and adolescents was accepted. It shows good efficacy and safety.
Toxys Reports Positive Results from the OECD Ring Trial Validation of ToxTracker in a Peer-Reviewed Article PharmaSources
April 10, 2024
Toxys announces the peer-reviewed publication of the positive results from an international interlaboratory validation of ToxTracker©.
Celonic Launches New GS-CHOvolution® Cell Line Expression System PharmaSources
April 10, 2024
GS-CHOvolution® is based on Revvity’s CHOSOURCE™ expression platform and TnT transposon technology.
Osteolabs to Present New Clinical Data from Over 2.400 OsteoTest Routine Samples at the WCO-IOF-ESCEO Congress PharmaSources
April 10, 2024
New data fully supporting potential for OsteoTest to qualify as new universal diagnostic method for early osteoporosis risk assessment and therapeutic control.